T2	condition 95 114	nausea and vomiting
T3	eligibility 118 192	women receiving combination of anthracycline/cyclophosphamide chemotherapy
T4	eligibility 647 678	women receiving AC chemotherapy
T5	No-of-participants 1184 1194	Forty-nine
T6	intervention-value 1233 1252	Sixty-three percent
T7	outcome 1264 1281	complete response
T8	control-value 1327 1330	39%
T9	intervention-value 1364 1375	Ten percent
T10	outcome 1393 1409	vomiting episode
T11	control-value 1443 1446	15%
T12	control 898 926	3 days regimen of aprepitant
T1	intervention 34 44	aprepitant
